Cowen and Company’s Biote Corp. Warrant BTMDW Stock Holding History

Cowen and Company’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-148,298	Closed	-$44.5K	–	749
2022 Q4	$44.5K	Buy	+148,298	New	+$40.4K	﹤0.01%	268
2022 Q1	–	Sell	-37,437	Closed	-$27K	–	794
2021 Q4	$27K	Buy	+37,437	New	+$30.2K	﹤0.01%	499

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cowen and Company's BTMDW Position: Q1 2023 in Review

Cowen and Company sold out of Biote Corp. Warrant (BTMDW) in Q1 2023, closing a stake of 148,298 shares — an estimated $44.5K sold.

Cowen and Company first reported a position in BTMDW in Q4 2021 and held it in 2 quarters. The position peaked at $44.5K in Q4 2022. 34 funds tracked by Wall St. Rank hold BTMDW as of Q1 2023.

Cowen and Company reported no remaining Biote Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Cowen and Company sold 148,298 Biote Corp. Warrant shares in Q1 2023, an estimated $44.5K.
Cowen and Company first reported a position in Biote Corp. Warrant in Q4 2021 and held it in 2 quarters.
Cowen and Company's Biote Corp. Warrant position peaked at $44.5K in Q4 2022.
34 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.